MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1

Historical Holders from Q1 2014 to Q3 2020

Type / Class
Debt / NOTE 4.500% 7/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 across Reporting Periods

Period Principal Value Change Price Investors
2020 Q3 0 $0 -$24,000 0
2020 Q2 26,000 $24,000 -$23,000 $0.9600 2
2020 Q1 51,000 $47,000 $0.9200 3
2019 Q4 51,000 $47,000 $0 $0.9200 3
2019 Q3 26,000 $24,000 $0 $0.9600 2
2019 Q2 26,000 $24,000 $0.9600 2
2019 Q1 26,000 $24,000 $0.9600 2
2018 Q4 26,000 $24,000 +$23,000 $0.9600 2
2018 Q3 1,000 $1,000 $1.00 1
2018 Q2 1,000 $1,000 $1.00 1
2018 Q1 1,000 $1,000 $1.00 1
2017 Q4 1,000 $80,000 -$42,502,000 $80.00 1
2017 Q3 48,620,000 $42,503,000 -$3,266,849 $0.8571 10
2017 Q2 52,419,000 $38,302,000 $0.7448 9
2017 Q1 52,419,000 $43,558,000 -$179,247 $0.8380 9
2016 Q4 52,609,000 $49,876,000 -$2,913,950 $0.9410 8
2016 Q3 52,604,000 $65,197,000 +$105,815 $1.25 11
2016 Q2 53,214,000 $59,218,000 -$87,974,811 $1.12 12
2016 Q1 115,416,000 $173,610,000 +$24,942,508 $1.50 15
2015 Q4 98,913,000 $145,895,000 -$25,839,174 $1.48 15
2015 Q3 114,919,000 $180,255,000 +$431,151 $1.57 16
2015 Q2 113,394,000 $238,347,000 -$7,108,800 $2.10 16
2015 Q1 116,925,000 $234,281,000 +$2,097,484 $2.00 15
2014 Q4 116,770,000 $221,898,000 +$5,525,734 $1.90 16
2014 Q3 113,943,000 $177,353,000 +$10,432,922 $1.55 16
2014 Q2 109,690,000 $147,492,000 +$4,620,806 $1.34 20
2014 Q1 108,007,000 $109,741,000 +$319,874 $1.01 24